Company Overview
Clario is a leading entity in clinical trial management, specializing in cutting-edge data management solutions for clinical research. By leveraging its deep scientific expertise and extensive global network, Clario offers one of the most comprehensive endpoint technology platforms available. This enables the company to enhance data reliability across decentralized, hybrid, and site-based trials, ultimately aiming to improve patient outcomes through superior research capabilities.
Leadership Team
- Chris Fikry, M.D. serves as the President and CEO, bringing nearly two decades of experience in medical device development and leadership roles from companies like Thermo Fisher Scientific, Quest Diagnostics, and Novartis.
- Jason Knoblauch, the Chief Financial Officer, contributes significant financial expertise and has a history of steering IPOs successfully.
- Terry Burke, Executive Vice President, manages the eCOA business and brings over 30 years in clinical diagnostics to optimize client relations.
- Jay Ferro, Chief Information, Technology, and Product Officer, focuses on data protection and strategic IT initiatives.
- David Fusco, EVP and Chief Human Capital Officer, brings extensive HR expertise specific to the life sciences sector.
- Julia James, EVP and Chief Legal and Administrative Officer, offers commercial and strategic oversight grounded in major legal transactions.
- Kristina Lowe is responsible for enhancing customer collaborations and data delivery as the head of Client Success and Customer Experience.
- Laurence Misztal, Senior Vice President and General Counsel, shapes global legal strategy with a focus on AI governance.
- Dr. Todd Rudo, Chief Medical Officer, optimizes clinical trial solutions across diverse therapeutic areas.
- Achim Schülke, Chief Innovation Officer, drives innovation in technology solutions for medical devices and trial markets.
- Ellen Street, EVP for Cardiac Safety, Respiratory, and Precision Motion, lends strategic leadership across disciplines.
- Dr. Joyce Suhy, EVP Medical Imaging and Specialty Solutions, contributes over 30 years of experience, particularly in imaging endpoints within clinical trials.
Products and Services
Clario provides an extensive range of endpoint technology services geared towards efficient clinical trial management. Its offerings include customizable medical devices specifically designed for biopharmaceutical and healthcare organizations, enhancing the generation of complex clinical evidence.
Recent Developments and Investments
Clario has attracted substantial investments from principal investors such as Astorg, Nordic Capital, and Athyrium Capital Management. These investments underscore Clario's robust market position and future growth potential. Currently privately held, Clario has plans to go public, targeting an IPO with an estimated valuation exceeding $10 billion.
Strategic Initiatives
In its strategic push, Clario emphasizes technological innovations, including introducing new translation service technology to significantly expedite eCOA study start-up times and broaden trial access globally.
Competitor Profiling
Clario is a dominant player within the clinical trial management systems domain, known for its digital solutions that streamline data collection and analysis. Its portfolio includes electronic data capture (EDC) tools and systems for randomization and trial supply management, backed by seamless integration with other clinical tools for optimized data management and efficiency.
Top Competitors
1. Medidata Solutions:
- Offers a comprehensive cloud-based clinical trial management system with strong scalability and advanced analytics.
- Notably offers a more complete platform compared to Clario, including EDC and other key trial management tools.
2. Oracle Clinical:
- Known for an enterprise-level platform capable of managing large-scale, complex clinical trials with integrated tools.
3. Veeva Systems:
- Provides industry-leading compliance tools and scalable solutions for a variety of trial sizes, though at a higher expense.
4. Cytel:
- Specializes in clinical trial design software, providing advanced analytics and biometric services.
5. Castor EDC:
- Features a user-friendly interface and flexibility that supports a wide range of trials, aligning with Clario's usability focus.
6. Viedoc:
- Employs blockchain technology for secure, decentralized trial management, emphasizing security and transparency.
7. REDCap:
- Provides a customizable platform for efficient research data capture, maintaining competitiveness with flexibility in applications.
Each competitor offers unique strengths, from advanced analytics and sophisticated compliance frameworks to decentralized and secure management platforms, challenging Clario to continuously innovate and expand its capabilities.
